Autor: "Sala, M" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study.
Autorzy:: Muñoz-Martínez S; Unitat d'Oncologia hepàtica, Liver Unit, Hospital Clínic, Barcelona, Spain.; BCLC group, IDIBAPS, Barcelona, Spain.; CIBEREHD, Barcelona, Spain.; Universitat de Barcelona (UB), Barcelona, Spain.
Sapena V; Unitat d'Oncologia hepàtica, Liver Unit, Hospital Clínic, Barcelona, Spain.; BCLC group, IDIBAPS, Barcelona, Spain.; Universitat de Barcelona (UB), Barcelona, Spain.; Medical Statistics Core Facility, Institut D'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Hospital Clinic Barcelona, Barcelona, Spain.
Forner A; Unitat d'Oncologia hepàtica, Liver Unit, Hospital Clínic, Barcelona, Spain.; BCLC group, IDIBAPS, Barcelona, Spain.; CIBEREHD, Barcelona, Spain.; Universitat de Barcelona (UB), Barcelona, Spain.
Bruix J; Unitat d'Oncologia hepàtica, Liver Unit, Hospital Clínic, Barcelona, Spain.; BCLC group, IDIBAPS, Barcelona, Spain.; CIBEREHD, Barcelona, Spain.; Universitat de Barcelona (UB), Barcelona, Spain.
Sanduzzi-Zamparelli M; Unitat d'Oncologia hepàtica, Liver Unit, Hospital Clínic, Barcelona, Spain.; BCLC group, IDIBAPS, Barcelona, Spain.; CIBEREHD, Barcelona, Spain.; Universitat de Barcelona (UB), Barcelona, Spain.
Ríos J; Department of Clinical Farmacology Hospital Clinic and Medical Statistics Core Facility, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Bouattour M; AP-HP, Hôpital Beaujon, Liver Cancer Unit, Clichy, France.
El-Kassas M; Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt.
Leal CRG; Gastroenterology, Hospital Universitário Antônio Pedro, Universidade Federal Fuminense, Rio de Janeiro, Brazil.; Gastroenterology, Hospital Federal do Servidores do Estado, Rio de Janeiro, Brazil.
Mocan T; 3rd Medical Department, 'Octavian Fodor' Institute for Gastroenterology and Hepatology, Cluj-Napoca, Romania.
Nault JC; Liver unit, Hôpital Avicenne, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance-Publique Hôpitaux de Paris, Bobigny, France.; Unité de Formation et de Recherche Santé Médecine et Biologie Humaine, Université Paris Nord, Communauté d'Universités et Etablissements Sorbonne Paris Cité, Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Equipe labellisée Ligue Nationale Contre le Cancer, Labex OncoImmunology. Université de Paris, team « Functional Genomics of Solid Tumors, Paris, France.
Alves RCP; Gastroenterology, Hospital do Servidor Publico Estadual de São Paulo, Sao Paulo, Brazil.; Bp Beneficência Portuguesa de São Paulo, Sao Paulo, Brazil.
Reeves HL; Liver Unit, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.; Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK.
da Fonseca L; Clinical Oncology, Sao Paulo Clinicas Liver Cancer Group. Instituto do Cancer do Estado de Sao Paulo. Hospital das Clínicas. University of Sao Paulo School of Medicine, Sao Paulo, Brazil.
García-Juárez I; Gastroenterology Department, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico.
Pinato DJ; Department of Surgery and Cancer, Imperial College London, London, UK.
Varela M; Liver Unit, Department of Digestive Disease, Hospital Universitario Central de Asturias, IUOPA, ISPA, Universidad de Oviedo, Oviedo, Spain.
Alqahtani SA; Liver Transplant, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Alvares-da-Silva MR; GI/Liver Unit, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Bandi JC; Hepatology Unit, Hospital Italiano, Buenos Aires, Argentina.
Rimassa L; Department of Biomedical Sciences, Humanitas University, Rozzano, Italy.; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS, Humanitas Research Hospital, Rozzano, Italy.
Lozano M; Aparato Digestivo, Hospital Universitario Infanta Leonor, Madrid, Spain.
González Santiago JM; Department of Gastroenterology and Hepatology, Salamanca University Clinic Hospital, IBSAL, CIBERehd, Salamanca, Spain.
Tacke F; Department of Gastroenterology and Hepatology, Salamanca University Clinic Hospital, IBSAL, CIBERehd, Salamanca, Spain.; Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany.
Sala M; Gastroenterology, Hepatology Unit, Hospital Doctor Josep Trueta, IDIBGI (Institut d'Investigació Biomèdica de Girona), CIBERehd, Girona, Spain.
Anders M; Hospital Aleman, Hepatología, Buenos Aires, Argentina.
Lachenmayer A; Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Piñero F; Liver Unit, Hospital Universitario Austral, Pilar, Argentina.
França A; Medicine, Federal University of Sergipe, Aracaju, Brazil.
Guarino M; Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Elvevi A; Division Gastroenterology and Center for Autoimmune Liver Diseases San Gerardo Hospital University of Milano - Bicocca School of Medicine, Monza, Italy.
Cabibbo G; Section of Gastroenterology and Hepatology, PROMISE, University of Palermo, Palermo, Italy.
Peck-Radosavljevic M; Innere Medizin & Gastroenterologie, Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria.
Rojas Á; SeLiver group. Institute of Biomedicine of Seville, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla-CIBERehd, Seville, Spain.
Vergara M; Unitat d'Hepatologia, Servei d'Aparell Digestiu, Parc Taulí Sabadell Hospital Universitari, Institut d'Investigació i Innovació I3PT, Universitat Autònoma de Barcelona, Barcelona, Departament de Medicina, Universitat Autònoma de Barcelona, CIBERehd. Instituto Carlos III, Madrid, Spain.
Braconi C; Medical Oncology, Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK.
Pascual S; Liver Unit. HGU Dr. Balmis. CIBERehd. ISABIAL, Alicante, Spain.
Perelló C; Gastroenterology and Hepatology, University Hospital Puerta de Hierro, Majadahonda, Spain.
Mello V; Oncology, AMO CLINIC, Salvador, Brazil.
Rodríguez-Lope C; Servicio de Aparato Digestivo, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
Acevedo J; South West Liver Unit, University Hospitals Plymouth NHS Trust, Plymouth, UK.
Villani R; Department of Medical and Surgical Sciences, Foggia, Italy.
Hollande C; AP-HP, Hôpital Beaujon, Liver Cancer Unit, Clichy, France.
Vilgrain V; Université de Paris, Paris, France.; Department of Radiology, Hôpital Beaujon, AP-HP. Nord, Clichy, France.
Tawheed A; Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt.
Ferguson Theodoro C; Department of Gastroenterology, Hospital Universitário Antônio Pedro, Universidade Federal Fluminense, Niteroi, Brazil.
Sparchez Z; 3rd Medical Department, Institute for Gastroenterology and Hepatology, University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Blaise L; Liver unit, Hôpital Avicenne, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance-Publique Hôpitaux de Paris, Bobigny, France.; Unité de Formation et de Recherche Santé Médecine et Biologie Humaine, Université Paris Nord, Communauté d'Universités et Etablissements Sorbonne Paris Cité, Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Equipe labellisée Ligue Nationale Contre le Cancer, Labex OncoImmunology. Université de Paris, team « Functional Genomics of Solid Tumors, Paris, France.
Viera-Alves DE; Gastroenterology, Hospital do Servidor Publico Estadual de São Paulo, Sao Paulo, Brazil.; Bp Beneficência Portuguesa de São Paulo, Sao Paulo, Brazil.
Watson R; Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK.
Carrilho FJ; Sao Paulo Clínicas Liver Cancer Group. Instituto do Cancer do Estado de Sao Paulo. Division of Clinical Gastroenterology and Hepatology, Hospital das Clínicas, Department of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil.
Moctezuma-Velázquez C; Gastroenterology Department, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico.
D'Alessio A; Department of Surgery and Cancer, Imperial College London, London, UK.; Department of Biomedical Sciences, Humanitas University, Rozzano, Italy.
Iavarone M; Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico - Division of Gastroenterology and Hepatology, Milan, Italy.
Reig M; Unitat d'Oncologia hepàtica, Liver Unit, Hospital Clínic, Barcelona, Spain.; BCLC group, IDIBAPS, Barcelona, Spain.; CIBEREHD, Barcelona, Spain.; Universitat de Barcelona (UB), Barcelona, Spain.; Pokaż więcej
Źródło:: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2022 Aug; Vol. 42 (8), pp. 1891-1901. Date of Electronic Publication: 2022 Jun 23.
Typ publikacji:: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: COVID-19*/complications
Carcinoma, Hepatocellular*
Liver Neoplasms*
COVID-19 Testing ; Cohort Studies ; Cross-Sectional Studies ; Humans ; Retrospective Studies ; SARS-CoV-2

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis.
Autorzy:: Díaz-González Á; Barcelona Clínic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic of Barcelona, IDIBAPS, Barcelona, Spain.
Sanduzzi-Zamparelli M; Barcelona Clínic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic of Barcelona, IDIBAPS, Barcelona, Spain.
da Fonseca LG; Barcelona Clínic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic of Barcelona, IDIBAPS, Barcelona, Spain.
Di Costanzo GG; Department of Transplantation, Liver Unit, Cardarelli Hospital, Naples, Italy.
Alves R; State Public Hospital, Sao Paulo, Brazil.
Iavarone M; CRC 'A. M. and A. Migliavacca' Center for Liver Disease, Division of Gastroenterology and Hepatology, IRCCS Cà Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Leal C; Gastroenterology and Hepatology Department, Federal Hospital of State Servants and Fluminense Federal University (Hospital Universitário Antônio Pedro), Río de Janeiro, Brazil.
Sacco R; Gastroenterology and Metabolic Diseases, Pisa University Hospital, Pisa, Italy.
Matilla AM; Digestive Diseases Department, University General Hospital Gregorio Marañón, Madrid, Spain.
Hernández-Guerra M; Liver Unit, Canary Island University Hospital, La Laguna, Spain.
Aballay Soteras G; Liver Transplant Unit, Hospital General de Agudos Dr Cosme Argerich, Buenos Aires Autonomous City, Argentina.
Wörns MA; First Department of Medicine, University Medical Centre of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Pinter M; Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Vienna Liver Cancer Study Group, AKH & Medical University of Vienna, Vienna, Austria.
Varela M; Liver Unit, Central University Hospital of Asturias, Institute of Oncology of Asturias (IUOPA), Foundation for Biosanitary Research and Innovation of the Principality of Asturias (FINBA), Oviedo, Spain.
Ladekarl M; Department of Oncology, Aarhus University Hospital, and Department of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aarhus, Denmark.
Chagas AL; Division of Clinical Gastroenterology and Hepatology, Department of Gastroenterology, University of São Paulo School of Medicine, Cancer Institute of the State of São Paulo, Sao Paulo, Brazil.
Mínguez B; Liver Unit, Department of Internal Medicine, Vall d'Hebron University Hospital, Vall d'Hebron Institut of Research, Center for Biomedical Research in Liver and Digestive Diseases Network (CIBERehd), Autonomous University of Barcelona, Barcelona, Spain.
Arenas JI; Digestive Diseases Department, Donostia University Hospital, San Sebastián, Spain.
Granito A; Unit of Internal Medicine, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Sánchez-Torrijos Y; UCM Digestive Diseases and Center for Biomedical Research in Liver and Digestive Diseases Network (CIBERehd), Institute of Biomedicine of Seville (IBiS), SeLiver Group, Virgen del Rocío/CSIC/US, Sevilla, Spain.
Rojas Á; UCM Digestive Diseases and Center for Biomedical Research in Liver and Digestive Diseases Network (CIBERehd), Institute of Biomedicine of Seville (IBiS), SeLiver Group, Virgen del Rocío/CSIC/US, Sevilla, Spain.
Rodríguez de Lope C; Digestive Diseases Department, Marqués de Valdecilla University Hospital, Marqués de Valdecilla Research Institute (IDIVAL), Santander, Spain.
Alvares-da-Silva MR; GI/Liver Unit, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Pascual S; Hepatic Unit, Gastroenterology Service, General University Hospital of Alicante, Center for Biomedical Research in Liver and Digestive Diseases Network (CIBERehd), Alicante, Spain.
Rimassa L; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center - IRCCS, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Lledó JL; Gastroenterology and Liver Diseases department, Ramón y Cajal University Hospital, Center for Biomedical Research in Liver and Digestive Diseases Network (CIBERehd), Madrid, Spain.
Huertas C; Digestive Diseases Department, Doctor Josep Trueta University Hospital, Girona, Spain.
Sangro B; Liver Unit, University of Navarra Clinic, Health Research Institute of Navarra (IDISNA), Center for Biomedical Research in Liver and Digestive Diseases Network (CIBERehd), Pamplona, Spain.
Giannini EG; Gastroenterology Unit, Department of Internal Medicine, IRCCS-San Martino Policlinico Hospital, University of Genoa, Genoa, Italy.
Delgado M; Digestive Diseases Department, La Coruña University Hospital, A Coruña, Spain.
Vergara M; Liver Unit, Digestive Diseases Department, Parc Taulí University Hospital, Parc Taulí I3PT Research and Innovation Institute, Autonomous University of Barcelona, Sabadell, Spain.
Perelló C; Liver Unit, Puerta de Hierro University Hospital, Puerta de Hierro Majadahonda Health Research Institute (IDIPHISA), Madrid, Spain.
Lue A; Digestive Diseases Department, Hepatology Unit and Liver Transplant, Lozano Blesa Clinical University Hospital, Zaragoza, Spain.
Sala M; Liver Unit, Digestive Diseases Department, Germans Trias i Pujol University Hospital, Center for Biomedical Research in Liver and Digestive Diseases Network (CIBERehd), Badalona, Spain.
Gallego A; Digestive Diseases Department, Santa Creu i Sant Pau University Hospital, Barcelona, Spain.
Coll S; Liver Section, Gastroenterology Department, Hospital del Mar, IMIM Hospital del Mar Medical Research Institute, Barcelona, Spain.
Hernáez T; Digestive Diseases Department, San Pedro Hospital, Logroño, Spain.
Piñero F; Liver Unit, Austral University Hospital, Buenos Aires, Argentina.
Pereira G; Gastroenterology and Hepatology Unit, Bonsucesso Federal Hospital, Ministry of Health, Río de Janeiro, Brazil.
França A; Liver Unit, Department of Medicine, Federal University of Sergipe, Sergipe, Brazil.
Marín J; Pablo Tobón Uribe Hospital, Medellín, Colombia.
Anders M; Liver Diseases and Liver Transplant Unit, German Hospital, Buenos Aires, Argentina.
Mello V; Multidisciplinary Assistance in Oncology (AMO) Clinic, Salvador, Brazil.
Lozano M; Digestive Diseases Department, Infanta Leonor University Hospital, Madrid, Spain.
Nault JC; Cordeliers Research Center, Sorbonne University, Inserm, USPC, Paris Descartes University, Paris Diderot University, Paris 13 University, Functional Genomics of Solid Tumors Laboratory, Jean Verdier Hospital, Paris-Seine-Saint University Hospital -Denis, Public Assistance Hospitals of Paris, Bondy, France.
Menéndez J; Liver Transplant and Liver Diseases Unit, Central Hospital of the Armed Forces (Military Hospital), Montevideo, Uruguay.
García Juárez I; Gastroenterology Department, National Institute of Medical Sciences and Nutrition Salvador Zubirán, City of Mexico, Mexico.
Bruix J; Barcelona Clínic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic of Barcelona, IDIBAPS, Barcelona, Spain.
Reig M; Barcelona Clínic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic of Barcelona, IDIBAPS, Barcelona, Spain.; Pokaż więcej
Źródło:: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2020 Jun; Vol. 40 (6), pp. 1467-1476. Date of Electronic Publication: 2020 Apr 15.
Typ publikacji:: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Agents*/adverse effects
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/drug therapy
Aged ; Europe ; Humans ; Niacinamide/adverse effects ; Phenylurea Compounds/adverse effects ; Renal Dialysis ; Sorafenib/therapeutic use ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Review article: natural history and prognostic prediction of patients with hepatocellular carcinoma.
Autorzy:: Varela M; Barcelona-Clínic Liver Cancer (BCLC) Group, Liver Unit IMD, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Catalonia, Spain.
Sala M
Llovet JM
Bruix J; Pokaż więcej
Źródło:: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2003 Jun; Vol. 17 Suppl 2, pp. 98-102.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Carcinoma, Hepatocellular/*etiology
Liver Neoplasms/*etiology
Carcinoma, Hepatocellular/diagnosis ; Humans ; Liver Neoplasms/diagnosis ; Neoplasm Staging/methods ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.
Autorzy:: Llovet JM; Liver Unit, Digestive Disease Institute, Hospital Clínic, University of Barcelona, Barcelona, Spain.
Real MI
Montaña X
Planas R
Coll S
Aponte J
Ayuso C
Sala M
Muchart J
Solà R
Rodés J
Bruix J; Pokaż więcej
Corporate Authors:: Barcelona Liver Cancer Group
Źródło:: Lancet (London, England) [Lancet] 2002 May 18; Vol. 359 (9319), pp. 1734-9.
Typ publikacji:: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Agents/*administration & dosage
Carcinoma, Hepatocellular/*therapy
Chemoembolization, Therapeutic/*methods
Doxorubicin/*administration & dosage
Liver Neoplasms/*therapy
Aged ; Carcinoma, Hepatocellular/mortality ; Carcinoma, Hepatocellular/pathology ; Cause of Death ; Female ; Humans ; Liver Neoplasms/mortality ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Survival Analysis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Sala, M"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język